AG
Artal Group Portfolio holdings
AUM
$930M
This Quarter Return
+36.7%
1 Year Return
-3.57%
3 Year Return
+157.23%
5 Year Return
+160.22%
10 Year Return
+1,359.85%
AUM
$4.37B
AUM Growth
+$4.37B
(+44%)
Cap. Flow
+$620M
Cap. Flow
% of AUM
14.19%
Top 10 Holdings %
Top 10 Hldgs %
43.92%
Holding
157
New
22
Increased
25
Reduced
24
Closed
21
Top Buys
| 1 |
Seer Inc
SEER
|
$328M |
| 2 |
SQZ
SQZ Biotechnologies Company
SQZ
|
$46.6M |
| 3 |
Zillow
Z
|
$45.4M |
| 4 |
IGMS
IGM Biosciences
IGMS
|
$45.1M |
| 5 |
Praxis Precision Medicines
PRAX
|
$41.3M |
Top Sells
| 1 |
BioNTech
BNTX
|
$59.6M |
| 2 |
Alibaba
BABA
|
$52.4M |
| 3 |
Moderna
MRNA
|
$26.1M |
| 4 |
StoneCo
STNE
|
$21.2M |
| 5 |
Scholar Rock
SRRK
|
$19.2M |
Sector Composition
| 1 | Healthcare | 82.45% |
| 2 | Consumer Discretionary | 9.72% |
| 3 | Technology | 2.14% |
| 4 | Communication Services | 1.97% |
| 5 | Real Estate | 1.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
WW
1
DELISTED
WW International
WW
| $362M | 7.76% | 14,818,300 | – | – |
|
|
2
Seer Inc
SEER
$115M
| $328M | 7.04% | +5,840,911 | New | +$328M |
|
|
ONC
3
BeOne Medicines Ltd. American Depositary Shares
ONC
$36.4B
| $258M | 5.55% | 1,000,000 +100,000 | +11% | +$25.8M |
|
4
Lexicon Pharmaceuticals
LXRX
$400M
| $243M | 5.23% | 71,178,364 +10,937,500 | +18% | +$37.4M |
|
|
XLRN
5
DELISTED
Acceleron Pharma Inc.
XLRN
| $179M | 3.85% | 1,400,000 | – | – |
|
6
Fate Therapeutics
FATE
$120M
| $127M | 2.73% | 1,400,000 -100,000 | -7% | -$9.09M |
|
|
MRTX
7
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $110M | 2.36% | 500,000 | – | – |
|
|
IGMS
8
DELISTED
IGM Biosciences
IGMS
| $106M | 2.27% | 1,200,000 +511,090 | +74% | +$45.1M |
|
9
Alnylam Pharmaceuticals
ALNY
$58.5B
| $104M | 2.23% | 800,000 | – | – |
|
|
10
Scholar Rock
SRRK
$3.14B
| $102M | 2.19% | 2,100,000 -395,140 | -16% | -$19.2M |
|
11
GDS Holdings
GDS
$6.62B
| $93.6M | 2.01% | 1,000,000 | – | – |
|
|
KLRS
12
Kalaris Therapeutics, Inc. Common Stock
KLRS
$76.3M
| $89.3M | 1.92% | 2,323,371 | – | – |
|
13
argenx
ARGX
$43.6B
| $88.2M | 1.89% | 300,000 -24,200 | -7% | -$7.12M |
|
|
14
BioNTech
BNTX
$24B
| $81.5M | 1.75% | 1,000,000 -731,214 | -42% | -$59.6M |
|
15
Generation Bio
GBIO
$40.4M
| $79.8M | 1.71% | 2,814,191 | – | – |
|
16
TG Therapeutics
TGTX
$4.65B
| $78M | 1.68% | 1,500,000 | – | – |
|
|
17
Zillow
Z
$20.4B
| $71.4M | 1.53% | 550,000 +350,000 | +175% | +$45.4M |
|
18
Schrodinger
SDGR
$1.44B
| $63.1M | 1.36% | 797,445 -100,000 | -11% | -$7.92M |
|
19
KE Holdings
BEKE
$20.8B
| $61.5M | 1.32% | 1,000,000 +130,000 | +15% | +$8M |
|
20
Amicus Therapeutics
FOLD
$2.34B
| $57.7M | 1.24% | 2,500,000 -500,000 | -17% | -$11.5M |
|
|
MORF
21
DELISTED
Morphic Holding, Inc. Common Stock
MORF
| $55.4M | 1.19% | 1,651,686 | – | – |
|
22
Atara Biotherapeutics
ATRA
$84.6M
| $55M | 1.18% | 2,800,000 +550,000 | +24% | +$10.8M |
|
23
Black Diamond Therapeutics
BDTX
$157M
| $52.8M | 1.13% | 1,646,517 +125,000 | +8% | +$4.01M |
|
|
SQZ
24
DELISTED
SQZ Biotechnologies Company
SQZ
| $46.6M | 1% | +1,606,308 | New | +$46.6M |
|
|
25
Alibaba
BABA
$322B
| $46.5M | 1% | 200,000 -225,000 | -53% | -$52.4M |
|